-
How big Pharma companies structure their licensing deals – prepare for BIO 2012
Most companies dream about closing a licensing deal with big Pharma. But what do these … Read more
-
Public Biotechs – Light at the end of the tunnel, although private Biotechs may have to wait a bit longer
Amsterdam March 2012: An overview of the state of the Biotech Industry was given by BIOs … Read more
-
Partnering and Investment – is the VC, Pharma, Biotech eco-system dead?
Partnering and Investment – is the VC, Pharma, Biotech eco-system dead? English (PDF) – 5 … Read more
-
Where does big pharma take the new drug discovery from?
Where does big pharma take the new drug discovery from? English (PDF) – 2 pages … Read more
-
Biotech Cluster Bay Area and Switzerland – a Comparison
Biotech Cluster Bay Area and Switzerland – a Comparison English (PDF) – 3 pages 116kb
-
Comparison of early stage funding in the US and EU – who gets more money?
Comparison of early stage funding in the US and EU – who gets more money? … Read more
-
BIO-Europe 2011: Early Stage Oncology Deals
BIO-Europe 2011: Early Stage Oncology Deals English (PDF) – 2 pages 192kb
-
-
-
BIO 2011: Deal-making in the Antibody Space
BIO 2011: Deal-making in the Antibody Space English (PDF) – 2 pages – 200kb